Triple HER2 blockade with trastuzumab, pertuzumab, and pyrotinib (TPPy) did not improve total pathological complete response (tpCR) rates or breast pathological complete response (bpCR) rates compared with dual blockade with trastuzumab and pertuzumab (TP), but was associated with greater grade ≥ 3 toxicity, particularly diarrhea.
Jiahui Huang +17 more
wiley +1 more source
Increased acid sphingomyelinase levels in saliva as oral mucositis severity predictors. [PDF]
Ordonez EBM +8 more
europepmc +1 more source
Mucositis and Peri-Implant Disease Treatment with Chitosan and Titanium Brushes: A Systematic Review. [PDF]
Pappolla Sessa C +4 more
europepmc +1 more source
ABSTRACT Introduction ONCOllab is a social media application developed by FDI to improve the management of oral complications that may arise during cancer therapy. This study aimed to evaluate the effects of ONCOllab on learning and perception among dental students.
Sara Samur Erguven +3 more
wiley +1 more source
Reactive Infectious Mucocutaneous Eruption Following Isolated Rhinovirus Infection: Clinical Presentation and Treatment Response. [PDF]
Verma KK +7 more
europepmc +1 more source
ABSTRACT Aims and Objectives This meta‐research study mapped systematic reviews on photobiomodulation (PBM), encompassing low‐level laser therapy (LLLT) and light‐emitting diode (LED) modalities, to evaluate whether protocols were registered, whether published reviews adhered to and updated their PROSPERO records, and whether topic redundancy occurred ...
Giovanna Marcilio Santos +7 more
wiley +1 more source
Immuno-protective impact of Kangfuxin liquid on systematic toxicity associated with autologous hematopoietic stem cell transplantation in multiple myeloma. [PDF]
Wu X +7 more
europepmc +1 more source
Efficacy of an Oscillating Chitosan Brush Versus an Air Abrasive Device in the Management of Peri-Implant Mucositis: A Randomized Clinical Trial. [PDF]
Bahçeci K, Gültekin BA, Yalçın S.
europepmc +1 more source
Patient-reported oral adverse events during cancer chemotherapy: longitudinal evaluation using patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) and concordance with clinician assessments. [PDF]
Sakai Y +4 more
europepmc +1 more source

